Collegium Pharmaceutical
COLL
71 hedge funds and large institutions have $305M invested in Collegium Pharmaceutical in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 10 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 15
76% more capital invested
Capital invested by funds: $173M → $305M (+$132M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 73 → 71 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
94% less call options, than puts
Call options by funds: $58K | Put options by funds: $963K
Top Buyers
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.34M |
| 2 |
Bank of New York Mellon
New York
|
-$2.63M |
| 3 |
AII
AGF Investments Inc
Toronto,
Ontario, Canada
|
-$1.32M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.2M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$1.13M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Neuberger Berman Group
New York
| – | -$237K | -20,000 | Closed |
|
|
HCM
77
Highbridge Capital Management
New York
| – | -$166K | -13,951 | Closed |
|
|
CCP
78
Clough Capital Partners
Boston,
Massachusetts
| – | -$162K | -13,700 | Closed |
|
|
ARTA
79
A.R.T. Advisors
New York
| – | -$148K | -12,500 | Closed |
|
80
Teacher Retirement System of Texas
Austin,
Texas
| – | -$22K | -1,819 | Closed |
|
81
JP Morgan Chase
New York
| – | -$1K | -48 | Closed |
|
COLL Hedge Fund Activity: Q3 2016 in Review
71 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2016, worth a combined $305M — up 76% from $173M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of COLL and 8 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 27 added.
The largest buyer was Cadian Capital Management, opening a new position worth an estimated $5.7M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.34M sold.
- 71 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2016, down from 73 in Q2 2016.
- Funds reported $305M of Collegium Pharmaceutical stock for Q3 2016, up 76% quarter-over-quarter.
- 8 funds opened new Collegium Pharmaceutical positions in Q3 2016 and 10 closed out, a net change of -2 holders.
- The largest Collegium Pharmaceutical buyer in Q3 2016 was Cadian Capital Management, an estimated $5.7M added.
- The largest Collegium Pharmaceutical seller in Q3 2016 was EcoR1 Capital, an estimated $3.34M sold.
Based on aggregated 13F filings for Q3 2016.